cyclopentane has been researched along with CAY10591 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mikami, Y; Murofushi, T; Suzuki, N; Tsuda, H; Yamaguchi, Y | 1 |
| Arora, M; Farghali, H; Kutinova Canova, N; Njeka Wojnarova, L | 1 |
2 other study(ies) available for cyclopentane and CAY10591
| Article | Year |
|---|---|
CAY10591, a SIRT1 activator, suppresses cell growth, invasion, and migration in gingival epithelial carcinoma cells.
Topics: Cell Division; Cell Line, Tumor; Cyclopentanes; Dimethyl Sulfoxide; Gingival Neoplasms; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Pyrroles; Quinoxalines; Reverse Transcriptase Polymerase Chain Reaction; Sirtuin 1 | 2017 |
Differentiated modulation of signaling molecules AMPK and SIRT1 in experimentally drug-induced hepatocyte injury.
Topics: Acetaminophen; AMP-Activated Protein Kinases; Animals; Chemical and Drug Induced Liver Injury; Cyclopentanes; Hepatocytes; Rats; Sirtuin 1 | 2023 |